2024-11-22 from mobihealthnews.com
Elon Musk's brain-computer interface implant startup Neuralink has received approval from Health Canada to perform a clinical trial on its N1 brain implant and R1 robot, which is used to place the implant into the brain.
The ‘Canadian Precise Robotically Implanted Brain-Computer Interface’ (CAN-PRIME) study will be performed by the University Health Network (UHN) hospital at its Toronto Western Hospital.
CAN-PRIME will assess the safety of the company's N1 implant, designed to allow individuals to control a computer or mobile device using their mind, and the company's R1 surgical ‘Robot, used to place each of the 64 threads of the N1 implant into a patient's brain.
The trial will evaluate the N1 and R1 robot in patients with tetraparesis or tetraplegia and is targeting Canadian residents with cervical spinal cord injury or the neurological disease ALS who also have a life expectancy of at least 12 months.
A team of experts at UHN will perform the surgical procedures.
Read. more here